Inhaled tobramycin improves lung function and bacterial density associated with Pseudomonas aeruginosa infections in patients with cystic fibrosis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 9, 2004-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Inhaled Tobramycin (TOBI®): A Review of its Use in the Management of Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis

By Cheer S.M.   Waugh J.   Noble S.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2501-2520

Adis International

Access to resources Recommend Favorite

Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the UK

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 46, Iss. 1, 2016-03 ,pp. : 15-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies

By Saint-Marcoux Franck  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1317-1328

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

By Hennig Stefanie   Wainwright Claire E.   Bell Scott C.   Miller Hugh   Friberg Lena E.   Charles Bruce G.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1099-1114

Adis International

Access to resources Recommend Favorite